Comparison

Rho/Rac/Cdc42 Activator I

Item no. CN04-B
Manufacturer Cytoskeleton
Amount 9 x 20 ug
Category
Type Activator
Specific against other
Citations Rom S., et al. 2013. Selective activation of cannabinoid receptor 2 in leukocytes suppresses their engagement of the brain endothelium and protects the blood&ndash,brain barrier. Am. J. Pathol. doi:10.1016/j.ajpath.2013.07.033.
Rom S., et al. 2012. Glycogen synthase kinase 3b inhibition prevents monocyte migration across brain endothelial cells via Rac1-GTPase suppression and down-regulation of active integrin conformation. Am. J. Pathol. 181:1414&ndash,1425.
ECLASS 10.1 42020190
ECLASS 11.0 42020190
UNSPSC 12000000
Alias Small G protein, Rac, Cdc42, Rac activator, Cdc42 activator, Rac1, Rac2, Rac3, Rac 1, Rac 2, Rac 3, Cdc 42
Similar products Rac2, Rac, Rac3, Cdc42, Rac1, Cdc 42, Rac 1, Small G protein, Rac 2, Rac 3, Rac activator, Cdc42 activator
Available
Additional info

Product Uses Include

  • Control for Rho, Rac and Cdc42 pathway activation

  • Study the effects of Rho family small G-protein activation on other signaling pathways

  • Study the cell-type specific cross-talk between signaling pathways for Rho, Rac and Cdc42

  • Study the effects of Rho family small G-protein activation on the re-arrangement of the actin cytoskeleton

Control for Rho, Rac and Cdc42 pathway activation

Study the effects of Rho family small G-protein activation on other signaling pathways

Study the cell-type specific cross-talk between signaling pathways for Rho, Rac and Cdc42

Study the effects of Rho family small G-protein activation on the re-arrangement of the actin cytoskeleton

    The active site of CN04 is based on the catalytic domain of the bacterial cytotoxic necrotizing factor (CNF) toxins. The catalytic domain is covalently attached to a proprietary cell penetrating moiety. CN04 directly activates Rho GTPase isoforms by deamidating glutamine-63 of Rho and glutamine-61 of Rac and Cdc42 in their respective Switch II regions (1, 2). This modification converts glutamine-63 to glutamate, which blocks intrinsic and GAP-stimulated GTPase activity, resulting in constitutively active endogenous Rho, Rac and Cdc42 (3). CN04 robustly increases the level of GTP-bound RhoA, Rac1 and Cdc42 within 2-4 h after addition to the culture medium. CN04 can be used when a direct activator of Rho family proteins is required rather than a classic indirect activator (e.g., LPA, EGF, Bradykinin and Sphingosine-1-phosphate) that concomitantly activate other signaling pathways (e.g., Ras, PI3K and PLC).

    References

    1. Lerm M., et al. 1999. Deamidation of Cdc42 and Rac by Escherichia coli cytotoxic necrotizing factor 1: activation of c-Jun N-terminal kinase in HeLa cells. Infection and immunity. 67, 496-503.


    2. Schmidt G., et al. 1997. Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1. Nature. 387, 725-729.


    3. Flatau G., et al. 1997. Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine. Nature. 387, 729-733.

    Above : Rac activation in Swiss 3T3 cells. F-actin is visualized with fluorescent green phalloidin staining (Cat.# PHDG1) and nuclear blue DNA staining with Dapi. Cells were activated with Cat. # CN04 (right).

    Delivery Time
    1-2 Weeks
    Shipping Temp.
    AT
    Storage on Arrival
    4C
    faqs

    Question 1:  Can the direct Rho/Rac/Cdc42 activator CN04 be used with cells growing in culture?

    Answer 1:  Yes, CN04 is specifically designed to be used as a Rho/Rac/Cdc42 activator with cultured cells.  The active site of CN04 is based on the catalytic domain of the bacterial cytotoxic necrotizing factor (CNF) toxins.  The catalytic domain of CN04 is covalently attached to a proprietary cell penetrating moiety.  Upon entry into the cell, CN04 directly activates Rho GTPase isoforms by deamidating glutamine-63 of Rho and glutamine-61 of Rac and Cdc42 in their respective Switch II regions. This modification converts glutamine-63 to glutamate, which blocks intrinsic and GAP-stimulated GTPase activity, resulting in constitutively active endogenous Rho, Rac and Cdc42.  CN04 robustly increases the level of GTP-bound RhoA, Rac1 and Cdc42 within 2-4 h after addition to the culture medium.

     

    Question 2:  How can I assess whether Rho, Rac and/or Cdc42 activity is changing in my cells following CN04 treatment? 

    Answer 2:  There are multiple ways to measure changes in Rho, Rac and Cdc42 activity.  To visualize a change in a cell&rsquo, s cytoskeleton mediated by Rho family proteins, we recommend examining stress fiber formation and edge ruffling with fluorescently-labeled phalloidin (Cat. # PHDG1, PHDH1, PHDN1, PHDR1).  These Acti-stain phalloidins label F-actin-containing structures and fibers.  Activation of Rho family proteins can be directly quantified with either our pull-down or G-LISA activation assays.  For RhoA, use the BK036 pull-down or BK 124 G-LISA.  For Rac1, use the BK035 pull-down or BK128 G-LISA.  For Cdc42, use the BK034 pull-down or BK127 G-LISA.

     

      If you have any questions concerning this product, please contact our Technical Service department at infohoelzel.de.

    Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

    All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

    Amount: 9 x 20 ug
    Available: In stock
    available

    Compare

    Add to wishlist

    Get an offer

    Request delivery time

    Ask a technical question

    Submit a bulk request

    Questions about this Product?